| Project Title |
Year |
Funding Body |
£ |
| Programme for donor eye retrieval for transplantation and research |
2012 |
NHSBT |
£140k |
| Regulatory support towards a novel standardised biological bandage for enhanced wound healing and tissue engineering |
2012 |
HERMES Fellowship UoN |
£10k |
| A novel standardised biological bandage for enhanced wound healing and tissue engineering |
2012 |
HERMES Fellowship UoN |
£27k |
| Planned multicentre trial of Combination of Ozurdex and ranibizumab retinal vein occlusion (COMRADE) |
2012 |
Novartis |
£60k |
| The health economics of amniotic membrane versus synthetic polymer as a growth substrate for transplantable cells for ocular surface reconstruction |
2011 |
EPSRC (DTC) |
£90k |
| A novel tissue-engineered construct of hMSC corneal epithelium for ocular surface reconstruction |
2011 |
EPSRC (DTC) |
£90k |
| Unrestricted research grant from for laboratory research in AMD |
2011 |
Novartis |
£15k |
| A novel surgical membrane for improved ocular regeneration |
2011 |
East Midlands Biosciences Business Germinator |
£4k |
| In vivo validation of freeze-dried amniotic membranes (FDAM) in the management of acute chemical and thermal ocular surface burns for use in a pre-hospital setting |
2011 |
MOD [DSTL] |
£208k |
| Development of dedicated media for MET for commercialisation |
2011 |
CellnTec industrial partner, Switzerland |
£7k |
| REPAIR Phase 2 Multicentre study of efficacy and safety of ranibizumab in myopic CNV |
2010 |
Novartis |
£100k |
| Limbal Stem Cell (LSC) isolation and characterisation for ex vivo transplantation |
2010 |
RCSEdinburgh, UK |
£50k |
| The use of wet-preserved versus augmented freeze-dried amniotic membranes in the management of acute chemical and thermal ocular surface burns in a pre-hospital setting |
2009 |
MOD [DSTL] |
£289k |
| Case-Crossover Study of PDE5 Inhibitor as factor in AION |
2009 |
Pfizer |
£45k |
| Assessment of pathways and genes associated with AMD Genetic Study of AMD, International Collaborator |
2009 |
NIH Grant USA |
$300k (of $5mil) |
| Commonwealth PhD secondment exchange programme |
2008 |
Commonwealth |
£20k |
| Human mesenchymal stem cells for ocular surface reconstruction |
2008 |
NERC |
£50k |
| A novel Spongy layer-derived medicament for ophthalmic and wound healing applications |
2008 |
UoN Knowledge Transfer Initiative |
£25k |
| A novel Spongy layer-derived medicament for ophthalmic |
2008 |
Okto Ophtho Industrial |
$10k |
| Transdifferentiation of human mesenchymal stem cells (hMSC) into corneal epithelial cells (CEC): Characterisation of gene and protein expression |
2008 |
UoN III Small Grants Scheme |
£10k |
| Programme for donor eye retrieval for transplantation and research |
2008 |
UKTransplant Authority |
£210k |
| SUSTAIN Phase 3b. Protocol CRFB002A23032006-8 |
2008 |
Novartis |
£140k |
| Characterisation of the role of microbicidal Ribonucleases (RNases) as novel ocular surface HDPs |
2008 |
RCSEdinburgh, UK |
£39k |
| Novel Bio-synthetic Matrix For Ocular Surface Reconstruction |
2008 |
MRC Discipline Hopping |
£92k |
| A novel biosynthetic bandage for corneal wound repair |
2005 |
EPSRC |
£118k |